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ABSTRACT
Objectives: Hepatokines are proteins secreted by the liver that impact the functions of the liver and various tissues through autocrine, paracrine,
and endocrine signaling. Recently, Tsukushi (TSK) was identified as a new hepatokine that is induced by obesity and cold exposure. It was
proposed that TSK controls sympathetic innervation and thermogenesis in brown adipose tissue (BAT) and that loss of TSK protects against diet-
induced obesity and improves glucose homeostasis. Here we report the impact of deleting and/or overexpressing TSK on BAT thermogenic
capacity, body weight regulation, and glucose homeostasis.
Methods: We measured the expression of thermogenic genes and markers of BAT innervation and activation in TSK-null and TSK-
overexpressing mice. Body weight, body temperature, and parameters of glucose homeostasis were also assessed in the context of TSK loss
and overexpression.
Results: The loss of TSK did not affect the thermogenic activation of BAT. We found that TSK-null mice were not protected against the
development of obesity and did not show improvement in glucose tolerance. The overexpression of TSK also failed to modulate thermogenesis,
body weight gain, and glucose homeostasis in mice.
Conclusions: TSK is not a significant regulator of BAT thermogenesis and is unlikely to represent an effective target to prevent obesity and
improve glucose homeostasis.
 2019 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
The liver plays a central role in regulating systemic metabolism. Al-
terations in liver functions linked to chronic overfeeding and obesity
contribute to the development of several health issues including insulin
resistance, type 2 diabetes, dyslipidemia, hypertension, and cardio-
vascular diseases [1,2]. Recent evidence indicates that the liver has an
impact on metabolism through the secretion of specific proteins. These
proteins, often referred to as hepatokines, are secreted by the liver and
have an impact on the functions of not only the liver per se but also
several extrahepatic tissues through autocrine, paracrine, and
endocrine mechanisms [3e5]. It is now well documented that the
secretion of several hepatokines is altered in response to obesity and
that some of these circulating proteins can directly contribute to the
development of obesity-related metabolic disorders [3e5].
Tsukushi (TSK) is an atypical member of the small leucine-rich pro-
teoglycan family that controls developmental processes in various
organisms [6]. Recently, two groups, including ours, reported the
identification of TSK as a new hepatokine [7e9]. These studies
revealed that TSK is a liver-derived factor whose expression and
circulating levels are strongly induced in response to obesity and cold
exposure. Triglyceride deposition in the liver, a common characteristic
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associated with obesity and acute cold challenge, is strongly associ-
ated with Tsk expression and TSK release by the liver [7,9]. It was also
shown that both inflammation and endoplasmic reticulum (ER) stress,
two conditions closely linked to excessive lipid deposition in the liver,
promote Tsk expression [7]. Collectively, these findings indicate that
TSK is a new hepatokine whose circulating levels are linked to hepatic
fat accumulation, inflammation, and ER stress.
The function of TSK in metabolism is becoming more clear. A recent
study proposed a role for TSK in regulating the activation of brown
adipose tissue (BAT), a key organ controlling thermogenesis, energy
balance, and glucose metabolism [8]. Using TSK-null mice, Wang et al.
reported that TSK loss increased sympathetic innervation and ther-
mogenesis in BAT, protected mice against diet-induced obesity, and
improved glucose homeostasis [8]. On the basis of these findings, they
proposed that TSK could be part of a negative feedback mechanism
emerging from the liver to repress thermogenesis in BAT and reduce
energy expenditure. TSK was thus suggested as a potential target for
therapeutic intervention in metabolic diseases. Here, we provide data
showing that the loss of TSK does not affect BAT thermogenic capacity.
We found that TSK-null mice are not protected against the develop-
ment of obesity and do not show improvement in glucose metabolism.
The overexpression of TSK also failed to modulate thermogenesis,
body weight, and glucose tolerance. Thus, we conclude that TSK in not
a significant regulator of BAT thermogenesis and that TSK is unlikely to
represent an effective target for preventing obesity and improving
glucose homeostasis.
2. MATERIALS AND METHODS
2.1. Animal care
All experimental protocols were approved by the Animal Ethics Com-
mittee of Université Laval (CPAUL) and were in accordance with the
guidelines of the Canadian Council on Animal Care. All mice were on a
C57BL/6J background and were purchased from the Jackson Labo-
ratory (stock no. 000664). Obese mice (ob/ob; stock no. 000632) were
also purchased from the Jackson Laboratory. The mice were main-
tained on a 12:12-h light-dark cycle (lights on 0600e1800) while
individually housed in ventilated cages at an ambient temperature of
23  1 C. Unless stated, all mice were fed ad libitum chow. Low-fat
diet (LFD; 10% kcal from fat, D12450B) and high-fat diet (HFD; 60%
kcal from fat, D12492) were purchased from Research Diets.
2.2. Generation of Tsk knockout mice
Tsk knockout mice were obtained from Genentech/Lexicon and
generated by homologous recombination, as described previously [10].
The insertion of the targeting vector was validated by polymerase chain
reaction (PCR) and southern blotting. The Tsk wild-type allele was
amplified using the following primers: forward 50-GACATCAATCT-
GAGCCATAAC-30, reverse 50-ATGAAGGCATCTGGGTTGATG-30. The
integration of the Neo Cassette in the mutant Tsk allele was measured
using the following primers: forward 50-GTAGACTCTCCA-
CAGGCATTGG-30, reverse 50- GCAGCGCATCGCCTTCTATC-30. The mice
were back-crossed for 6 generations onto C57BL6/J before being used
experimentally. All experiments were performed using age-matched
littermates produced by breeding Tsk heterozygote mice.
2.3. Cold exposure
Age-matched littermates (male) were individually housed in clean
cages and exposed to cold (10  1 C) for a period of 24 h. The mice
had free access to chow and water throughout the experiment.
2.4. Overexpression of TSK in mice
Adeno-associated virus (AAV) vectors were packaged by the Canadian
Neurophotonics Platform (Centre de recherche CERVO, QC, Canada).
Briefly, viral particles were generated from a triple transfection of HEK
293T17 cells and collected from the culture media 5 days post-
transfection. They were concentrated using a tangential flow filtration
setup (Vivaflow 50R 100K MWCO, Sartorius) and then purified by
iodixanol gradient and ultracentrifugation. The purified particles were
collected in suspension buffer (phosphate-buffered saline [PBS]
320 mM NaCl, 5% D-sorbitol, and 0.001% Pluronic F-68) and titrated
by quantitative PCR (qPCR; TaqMan) using an inverted terminal
repeatebased probe and primers. Physical titer and purity were
confirmed by separating the same volumes of AAV on 10% sodium
dodecyl sulfate (SDS)epolyacrylamide gel electrophoresis (stain free;
BioRad) in Tris-glycine-SDS buffer. Male C57BL6/J mice (10 weeks)
were injected with 100 mL of AAV8-GFP or AAV8-TSK through the tail
vein (1  1011 plaque-forming units/mouse). The animals were
sacrificed at the indicated time following the injection.
2.5. Quantitative real-time PCR (RT-qPCR)
Total mRNA was isolated from tissues using the RNeasy Lipid Tissue
Mini Kit (Qiagen, 74104). The RNA concentrations were estimated by
measuring the absorbance at 260 nm. cDNA synthesis was performed
using the iScript Advanced cDNA Synthesis Kit for RT-qPCR (Bio-
Rad) as described. mRNA extraction and cDNA synthesis were per-
formed according to the manufacturer’s instructions. cDNA was diluted
in DNase-free water (1:15) before quantification by real-time PCR.
mRNA transcript levels were measured in duplicate samples using
CFX96 or CFX384 touch real-time PCR (Bio-Rad, Mississauga, ON,
Canada). Chemical detection of the PCR products was achieved with
SYBR Green (Bio-Rad, 172e5271). At the end of each run, melt curve
analyses were performed, and representative samples of each
experimental group were run on agarose gel to ensure the specificity of
amplification. Gene expression was corrected for the expression level
of the reference gene. The following primers were used.
2.6. Glucose tolerance test (GTT) and insulin tolerance test (ITT)
For the glucose tolerance test (GTT), the mice were fasted for 6 h and
injected intraperitoneally (ip) with 1 g/kg of D-glucose. For the insulin
tolerance test (ITT), the mice were fasted for 6 h and injected ip with
0.75 U/kg of recombinant insulin (Humulin, Lilly, Canada). Blood
samples were collected from the tail vein, and glucose was measured
using a glucometer (Roche, Accu-Chek Performa).
2.7. Body composition analysis
Body composition was measured by dual-energy X-ray absorptiometry
(DEXA) using the PIXIMUS mouse densitometry apparatus (Lunar
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2.8. Body temperature measurement
Rectal temperature was measured in mice using a digital thermometer
with a precision of 0.1 C (Mansfield, Montreal, QC, Canada).
2.9. Western blotting
Tissues were lysed with Triton-X 100-containing lysis buffer (50 mM
HEPES, pH 7.4, 2 mM EDTA, 10 mM sodium pyrophosphate, 10 mM
sodium glycerophosphate, 40 mM NaCl, 50 mM NaF, 2 mM sodium
orthovanadate, 1% Triton-X 100, 0.1% sodium lauryl sulfate, and 1%
sodium deoxycholate and one tablet of EDTA-free protease inhibitors
per 25 ml). Tissues were rotated at 4 C for 10 min, and then the
soluble fractions of cell lysates were isolated by centrifugation for
10 min in a microcentrifuge. Protein levels were then quantified using
Bradford reagent and analyzed by western blotting. Samples were
loaded on 10% Tris-glycine precast gels (Life Technologies). Proteins
were transferred to polyvinylidene difluoride membranes and then
blocked in 5% milk diluted in PBS-Tween and incubated with their
corresponding primary antibodies overnight at 4 C. The following
primary antibodies were used: Akt (pan) (4691S, Cell Signaling
Technology, dilution 1:1000), b-actin (4967, Cell Signaling Technol-
ogy, dilution 1:1000), phospho-PKA substrate (RRXS*/T*)(100G7E)
(9624S), and tyrosine hydroxylase antibody (NB300-109, Novus,
dilution 1:1000). Secondary antibodies were purchased from Cell
Signaling Technology (7076S and 7074S) and diluted 1:5000. Amer-
sham ECL Western Blotting Detection Reagent (RPN2106) was used to
image the blots.
3. RESULTS
3.1. Loss of TSK does not affect BAT thermogenic capacity
TSK deficiency was recently shown to affect BAT function in mice [8].
An increase in thermogenic gene expression was reported in TSK-null
animals, an effect that was linked to elevated sympathetic innervation
and to a reduction in lipid deposition in BAT. To test the impact of TSK
loss on BAT metabolism, we used the full-body TSK-null mouse model
that was previously developed [10]. Confirming the validity of the
model, Tsk expression was undetectable in the liver of TSK knockout













































































































































































Figure 1: Loss of TSK does not affect BAT thermogenic capacity. (A) qPCR analysis of Tsk gene expression in the liver of wild-type (Tskþ/þ) and knockout (Tsk-/-) mice
(n ¼ 6e7/group). (B) qPCR analysis of thermogenic gene expression in the BAT of Tskþ/þ and Tsk-/- mice fed chow or HFD for 12 weeks (n ¼ 8e9/group). (C) Western blot
analyses performed on BAT protein lysates prepared from Tskþ/þ and Tsk-/- mice fed chow or HFD for 12 weeks. Representative samples are shown. (D) Quantification of TH
protein levels of samples described in panel C (n ¼ 5e7/group). The results are normalized to b-actin. (E) BAT weight of Tskþ/þ and Tsk-/- mice fed either chow or HFD diet for 12
weeks (n ¼ 8e9/group). Results are presented as percentage of body weight. (F) Body temperature of Tskþ/þ and Tsk-/- mice fed chow diet (n ¼ 6/group). Data are presented as
the mean  SEM. In panels A, D, and F, significance was determined by two-tailed, unpaired t test. *P < 0.05 versus control. In panels B and E, two-way analysis of variance with
Sidak’s multiple comparisons was performed. *P < 0.05 versus wild-type. Nonsignificant differences (n.s.) are indicated.
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thermogenic markers in BAT, including Uncoupling protein 1 (Ucp1),
Cell death activator CIDE-A (Cidea), Peroxisome proliferator-activated
receptor gamma coactivator 1a (Pgc1a), and Type II iodothyronine
deiodinase (Dio2). As shown in Figure 1B, none of these genes were
differentially expressed in the BAT of TSK-null mice as compared to the
expression in littermate controls. This was observed in mice fed either
chow or HFD. We next measured the phosphorylation of protein kinase
A (PKA) substrates and tyrosine hydroxylase (TH) in BAT as markers of
BAT activation and innervation. In contrast to the findings of Wang
et al., we found no increase in the phosphorylation of PKA substrates
and TH levels in TSK knockout mice (Figure 1C). In fact, we even
observed a reduction in TH protein in the BAT of chow-fed mice
(Figure 1C and 1D). No difference in BAT weight and body temperature
between wild-type and knockout mice further confirmed the absence
of thermogenic induction in the BAT of TSK-null mice (Figure 1E and
1F). To test whether TSK might specifically have an impact on BAT
activation in response to cold, wild-type and TSK-null mice were
housed at 10 C for 24 h. As shown in Figure S1, TSK loss did not
increase the expression of the thermogenic gene, the phosphorylation
of PKA substrates, or TH levels in BAT. The weight of BAT did not differ
between wild-type and TSK null mice. Altogether, these results do not
support a role for TSK in regulating BAT thermogenesis in mice.
3.2. Loss of TSK does not protect mice against the development of
obesity
The elevation in BAT activity caused by TSK deletion was proposed to
be sufficient to promote energy expenditure and prevent diet-induced
obesity in mice [8]. To test the impact of TSK on body weight
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Figure 2: Loss of TSK does not protect mice against obesity development. (A) Body weight and (B) percentage of body weight gain of Tskþ/þ and Tsk/- mice fed either a
LFD or a HFD diet for 19 weeks (n ¼ 6e8/group). (C) Percentage of lean and (D) fat mass measured by DEXA in mice described in A and B (n ¼ 6e8/group). (E) Body weight and
(F) percentage of body weight gain measured in ob/þ Tskþ/þ, ob/þ Tsk-/-, ob/ob Tskþ/þ, and ob/ob Tsk-/- mice (n ¼ 6e8/group). Data are presented as the mean  SEM. In
panels A to D, two-way analysis of variance (ANOVA) with Sidak’s multiple comparisons was performed. In panel A, body weight at week 20 was used in the analysis. Results from
the ANOVA are presented on the side of each panel. In panel F, significance was determined by two-tailed, unpaired t test. *P < 0.05 versus wild-type mice. Nonsignificant
differences (n.s.) are indicated.
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regulation, wild-type and TSK knockout littermates were fed either a
LFD or a HFD. At the beginning of the study, TSK-null animals were
already smaller than wild-type littermates, a phenotype consistent with
the established role of TSK in regulating development in mice (Figure.
2A) [6]. In contrast to the results presented by Wang et al., TSK-null
animals were not protected against diet-induced obesity. As shown
in Figure 2B, TSK wild-type and TSK knockout mice gained the same
amount of weight in response to LFD or HFD. Supporting these find-
ings, DEXA analyses revealed no difference in lean and fat mass be-
tween the wild-type and TSK-null mice (Figure 2C and 2D). To test
whether TSK loss could have an impact on body weight gain in
severely obese mice, TSK wild-type and TSK knockout mice were
established into the ob/þ and ob/ob background, respectively.
Although TSK-null mice were smaller than littermate controls
(Figure 2E), the body weight gain measured in the ob/ob background
was not affected by the loss of TSK (Figure 2F). These results further
confirm that loss of TSK does not protect mice against the development
of obesity.
3.3. Loss of TSK does not improve glucose homeostasis
The loss of TSK was previously reported to improve glucose tolerance
in mice [8]. To define the impact of TSK loss on glucose metabolism,
we next performed the GTT in TSK wild-type TSK and knockout mice
fed either a LFD or a HFD. We observed a mild deterioration in glucose
tolerance in TSK knockout mice fed aLFD, but this effect was not
statistically significant when the area under the curve was calculated
(Figure 3A and B). More importantly, we did not find an impact of TSK
loss on glucose intolerance induced by HFD feeding (Figure 3A and B).
To test whether TSK loss could have an impact on glucose homeo-
stasis in genetically obese mice, we performed GTT in TSK wild-type
and TSK knockout mice bred into the ob/ob background. As pre-
sented in Figure 3C and D, we found no effect of TSK loss on glucose
tolerance in this more severe model either. Altogether, these results
indicate that TSK does not improve glucose homeostasis in two well-
established mouse models of obesity.
3.4. Overexpression of TSK does not affect BAT thermogenic
capacity, body weight, and glucose homeostasis
To further examine the functions of TSK in regulating metabolism, com-
plementary experiments were performed in TSK-overexpressing mice.
Briefly, mice were infected with AAV serotype 8 (AAV8) coding for either a
control green fluorescent protein (GFP) or a full-length TSK. As expected,
we detected high levels of TSK in the plasma of mice injected with AAV8-
TSK (Figure 4A). As observed in TSK-null mice, TSK overexpression did
not affect the expression of thermogenic genes in BAT (Figure 4B). We did
not observe any change in BAT weight or obvious differences in BAT
morphology between AAV8-GFP and AAV8-TSK mice (Figure 4C and D).
Moreover, we measured no difference in body temperature following TSK
overexpression (Figure 4E). Consistent with these findings, we found no
effect of TSK overexpression on body weight gain (Figure 4F). We next
sought to define the impact of TSK overexpression on glucose homeo-
stasis. As depicted in Figure 4G and H, TSK overexpression did not have
any impact on glucose tolerance and insulin sensitivity. Overall, these
results indicate that TSK overexpression does not affect BAT activation,
body weight, and glucose homeostasis in mice.
4. DISCUSSION
Hepatokines are proteins released by the liver that have an impact on
various organs to control systemic metabolism. The secretion of
several hepatokines is altered in response to obesity, and growing
evidence indicates that these changes can contribute to the develop-
ment of glucose intolerance, insulin resistance, and cardiovascular
diseases [3e5]. These observations suggest that hepatokines could
represent new targets for the treatment of obesity-related metabolic
diseases.
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Figure 3: Loss of TSK does not improve glucose homeostasis. (A) Glucose tolerance test (GTT) performed in Tskþ/þ and Tsk-/- mice fed either LFD or HFD (6e8/group). (B)
Presentation of the area under the curve (AUC) calculated from the experiment described in panel A. (C) Glucose tolerance test (GTT) performed in ob/þ Tskþ/þ, ob/þ Tsk-/-, ob/ob
Tskþ/þ, and ob/ob Tsk-/- mice (n ¼ 6e8/group). (D) Presentation of the AUC calculated from the experiment described in panel C. Data are presented as the mean  SEM. In
panels A to D, two-way analysis of variance (ANOVA) with Sidak’s multiple comparisons was performed. *P < 0.05 versus wild-type. In panels B and D, results from the ANOVA are
presented on the side of the graph. Nonsignificant differences (n.s.) are indicated.
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TSK is a newly identified hepatokine whose circulating levels are
induced by obesity and cold exposure [7e9]. Liver steatosis, a com-
mon feature associated with obesity and acute cold challenge, is
strongly associated with circulating TSK in several mouse models
[7,9]. Interestingly, both inflammation and ER stress, two conditions
linked to excessive lipid deposition in the liver, promote hepatic Tsk
expression in mice [7]. Generally, these findings support the idea that
TSK is produced when the liver faces various stressful conditions
linked to excessive lipid flux in the tissue. Although both groups
reporting the discovery of TSK generally agree on the conditions
promoting its release by the liver, they also proposed different phys-
iological roles for this hepatokine. Gain- and loss-of-function studies
performed in our laboratory revealed that TSK has an impact on sys-
temic cholesterol homeostasis [7]. In particular, we showed that TSK
reduced circulating high-density lipoprotein cholesterol, lowered
cholesterol efflux capacity, and decreased the conversion of choles-
terol to bile acid in the liver. On the basis of these findings, we propose
that TSK might be part of a biological response aimed at limiting
reverse cholesterol transport to the liver when hepatocytes are
exposed to elevated lipid flux, inflammation, and ER stress. Alterna-
tively, because TSK is rapidly induced following cold exposure, a
phenomenon that we found to be linked to the acute steatosis that
develops upon sympathetic activation, a role for TSK in the regulation
of thermogenesis was investigated [8]. In this study, Wang et al. re-
ported that TSK deletion increased sympathetic innervation and ther-
mogenesis in BAT, protected mice against diet-induced obesity, and
improved glucose homeostasis [8]. They proposed that TSK could be
part of a negative feedback mechanism emerging from the liver to
repress thermogenesis in BAT and reduce energy expenditure.
With our past experience in the study of BAT and energy balance [11e
17], we intuitively tested the effect of TSK on these parameters soon
after the identification of TSK, with the objective of testing the possible
role of this protein in the control of energy metabolism. Here, we
provide compelling evidence showing that TSK does not impact the
thermogenic activation of BAT under various experimental conditions.
These results clearly show that neither the loss nor the overexpression
of TSK has an effect on the expression of classical markers of ther-
mogenesis in BAT. In these experiments, TSK did not affect body
temperature and body weight gain in both lean and obese mice.
Moreover, we did not observe any significant impact of TSK loss or
overexpression on glucose homeostasis. Collectively, these observa-
tions raise questions about the importance of TSK in modulating BAT
activation in mice, as recently proposed by Wang and colleagues [8].
The underlying reasons for these discrepant findings remain to be fully
investigated, but it is worth pointing out some key experimental con-
siderations that are likely contributing to the phenotypical discordance
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Figure 4: Overexpression of TSK does not affect BAT thermogenic capacity, body weight, and glucose homeostasis. (A) Western blot analysis of plasma collected from
C57BL/6J mice injected with AAV8-GFP or AAV8-TSK. Plasma was collected 4 weeks following AAV8 injection. Representative samples are shown. (B) qPCR analyses of
thermogenic gene expression in the BAT of AAV8-GFP and AAV8-TSK mice sacrificed 4 weeks post injection (n ¼ 8/group). (C) BAT weight of AAV8-GFP and AAV8-TSK mice
(n ¼ 12/group). (D) Hematoxylin and eosinestained sections of BAT samples collected from AAV8-GFP and AAV8-TSK mice. Representative samples are shown. (E) Body
temperature of AAV8-GFP and AAV8-TSK mice 4 weeks post injection (n ¼ 7e8/group). (F) Body weight of AAV8-GFP and AAV8-TSK mice (n ¼ 12/group). (G) GTT and (H) ITT
performed in AAV8-GFP and AAV8-TSK mice (n ¼ 12/group). Data are presented as the mean  SEM. In panels B, C, and E, significance was determined by two-tailed, unpaired t
test. *P < 0.05 versus control. In panels F to H, two-way analysis of variance with Sidak’s multiple comparisons was performed. *P < 0.05. The absence of an asterisk denotes no
significant (n.s.) changes between the groups.
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between the studies. First, the TSK knockout models used by our
respective teams were generated by two independent groups that used
embryonic stem cells originating from different mouse strains (129S5/
SvEvBrd vs. C57BL6 x CBA) [10,18]. Although both knockout mice were
backcrossed to C57BL6J for six generations, differences in the genetic
background may have persisted between the models, which could have
been sufficient to alter the response to TSK loss. The impact of genetic
background on thermogenesis has been well documented over the years
[19,20]. Further supporting the differences between the two TSK
knockout lines, a delay in hair cycle development was found in the TSK
knockout mice used by Wang et al. [21], a phenotype that we did not
observe in our model (Figure S2). Skin defects were also found in their
TSK knockout mouse model [22]. As recently discussed by Nedergaard
and Cannon, changes in the quality of skin, fur, and hair can reduce
insulation and promote heat loss, which is often sufficient to activate the
sympathetic nervous system and increase energy expenditure [23].
Taking this into account, it is thus possible that the link between TSK and
BAT thermogenesis reported by Wang et al. may have been revealed
secondary to a defect in heat conservation. The fact that their TSK
knockout mice no longer show elevated BAT activity and protection
against obesity when housed at thermoneutrality supports this hypoth-
esis [8]. Lastly, we cannot exclude the possibility that variations in diet
composition, housing conditions, or gut microbiota composition may
have affected the biological outcomes of each study [24].
Although the experimental differences described above could explain
part of the discordance between our studies with the TSK-null mouse
models, they do not explain why TSK overexpression had no impact on
BAT activation, body weight regulation, and glucose homeostasis.
Collectively, the lack of effect of both TSK loss and overexpression on
BAT activation and body weight regulation in our mouse models argues
against a significant role of TSK in regulating thermogenesis and en-
ergy balance in mice.
5. CONCLUSION
Taken together, our data provide clear evidence that neither the loss
nor the overexpression of TSK has any significant impact on BAT
thermogenic capacity, body weight gain, and glucose homeostasis in
mice. We thus feel that the conclusions drawn by Wang et al. should be
interpreted with caution until additional studies from independent
groups confirm or refute our respective findings.
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